Chinook Therapeutics, Inc. Free Cash Flow 2015-2023 | KDNY
Chinook Therapeutics, Inc. free cash flow from 2015 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Chinook Therapeutics, Inc. Annual Free Cash Flow |
| 2022 |
-119.13 |
| 2021 |
-104.36 |
| 2020 |
-56.50 |
| 2019 |
-14.35 |
| 2018 |
-71.08 |
| 2017 |
-94.01 |
| 2016 |
-109.96 |
| 2015 |
152.64 |
| 2014 |
18.58 |
| 2013 |
-14.40 |
| Chinook Therapeutics, Inc. Quarterly Free Cash Flow |
| 2023-06-30 |
-113.41 |
| 2023-03-31 |
-51.60 |
| 2022-12-31 |
-119.13 |
| 2022-09-30 |
-81.62 |
| 2022-06-30 |
-55.94 |
| 2022-03-31 |
-25.10 |
| 2021-12-31 |
-104.36 |
| 2021-09-30 |
-81.47 |
| 2021-06-30 |
-55.99 |
| 2021-03-31 |
-28.41 |
| 2020-12-31 |
-56.50 |
| 2020-09-30 |
-14.55 |
| 2020-06-30 |
-7.61 |
| 2020-03-31 |
-3.51 |
| 2019-12-31 |
-14.35 |
| 2019-09-30 |
-44.62 |
| 2019-06-30 |
-27.97 |
| 2019-03-31 |
-11.63 |
| 2018-12-31 |
-71.08 |
| 2018-09-30 |
-69.66 |
| 2018-06-30 |
-45.77 |
| 2018-03-31 |
-22.72 |
| 2017-12-31 |
-94.01 |
| 2017-09-30 |
-67.94 |
| 2017-06-30 |
-45.57 |
| 2017-03-31 |
-23.58 |
| 2016-12-31 |
-109.96 |
| 2016-09-30 |
-80.03 |
| 2016-06-30 |
-36.43 |
| 2016-03-31 |
-24.73 |
| 2015-12-31 |
152.64 |
| 2015-09-30 |
155.94 |
| 2015-06-30 |
172.56 |
| 2015-03-31 |
-8.79 |
| 2014-12-31 |
18.58 |
| 2014-09-30 |
-6.23 |
| 2014-06-30 |
3.69 |
| 2014-03-31 |
-5.10 |
